Despite being known risk factors for poor cardiovascular outcomes, blood pressure and low-density lipoprotein (LDL) cholesterol remain undertreated among a large proportion of patients. To address this gap, a team from Brigham ...
Nov 17, 2020
0
22
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called "bad" cholesterol—by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard ...
Nov 15, 2020
0
78
DEAR MAYO CLINIC: I recently had an annual well check with my primary care doctor and was told I have high cholesterol. I know it runs in my family, but I am 25 and thought I was eating well enough and exercising. I do not ...
Oct 16, 2020
0
0
(HealthDay)—For patients with homozygous familial hypercholesterolemia, evinacumab lowers low-density lipoprotein (LDL) cholesterol levels, according to a study published in the Aug. 20 issue of the New England Journal ...
Aug 20, 2020
0
2
A new study is the first to show a food-based approach using clinically-proven diet interventions to lower cholesterol levels, such as Step One Foods, provides significant healthcare cost savings.
Aug 13, 2020
0
2
Heart disease patients taking evolocumab in addition to a statin to achieve extremely low levels of cholesterol do not show increased incidence of neurocognitive impairments, including memory loss or reduction in executive ...
May 4, 2020
0
43
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...
Mar 30, 2020
0
0
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial ...
Mar 30, 2020
0
0
Treating younger people with high cholesterol levels may help reduce their risk of heart attack or stroke in later life, a major study showed Wednesday.
Dec 4, 2019
0
19
(HealthDay)—A high proportion of patients with atherosclerotic cardiovascular disease (ASCVD) do not achieve recommended low-density lipoprotein cholesterol (LDL-C) goals, according to a study presented at the annual meeting ...
Nov 15, 2019
0
1
